迈瑞医疗：龙华科技产业园已于2022年启动建设

证券之星09-01 16:03

证券之星消息，迈瑞医疗(300760)09月01日在投资者关系平台上答复投资者关心的问题。

投资者提问：董秘你好，请问深圳龙华迈瑞医疗供应链科技园一期有无完成竣工验收及竣工备案，预计何时投产、何时财务转固？

迈瑞医疗回复：您好，谢谢关注。迈瑞医疗全球制造基地——龙华科技产业园已于2022年启动建设。龙华基地用地面积约为12.8万平方米，总投资22亿元，建成后将承载公司60%以上的产能。龙华科技产业园将全面推进智能化、自动化、信息化发展，将自身打造成为医疗器械行业的制造标杆。谢谢。

本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。

责任编辑：刘浩然

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2664310108?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-01 16:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664310108","market":"hk","top_or_hot":-1,"title":"迈瑞医疗：龙华科技产业园已于2022年启动建设","media":"证券之星","content":"<html><body><p>证券之星消息，<a href=\"https://laohu8.com/S/300760\">迈瑞医疗</a>(300760)09月01日在投资者关系平台上答复投资者关心的问题。</p><p>投资者提问：董秘你好，请问深圳龙华迈瑞医疗供应链科技园一期有无完成竣工验收及竣工备案，预计何时投产、何时财务转固？</p><p>迈瑞医疗回复：您好，谢谢关注。迈瑞医疗全球制造基地——龙华科技产业园已于2022年启动建设。龙华基地用地面积约为12.8万平方米，总投资22亿元，<a href=\"https://laohu8.com/S/01630\">建成</a>后将承载公司60%以上的产能。龙华科技产业园将全面推进智能化、自动化、信息化发展，将自身打造成为医疗器械行业的制造标杆。谢谢。</p><p>本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。</p><p>责任编辑：刘浩然</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>迈瑞医疗：龙华科技产业园已于2022年启动建设</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n迈瑞医疗：龙华科技产业园已于2022年启动建设\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-01 16:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026090100025533.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，迈瑞医疗(300760)09月01日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问深圳龙华迈瑞医疗供应链科技园一期有无完成竣工验收及竣工备案，预计何时投产、何时财务转固？迈瑞医疗回复：您好，谢谢关注。迈瑞医疗全球制造基地——龙华科技产业园已于2022年启动建设。龙华基地用地面积约为12.8万平方米，总投资22亿元，建成后将承载公司60%以上的产能。龙华科技产业园将...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026090100025533.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1720050803.USD","symbol_name":"安联全方位中国股票基金","start_time":0,"source_url":"https://stock.stockstar.com/RB2026090100025533.shtml","article_id":"2664310108","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664310108","pubTimestamp":1788249801,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，迈瑞医疗(300760)09月01日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问深圳龙华迈瑞医疗供应链科技园一期有无完成竣工验收及竣工备案，预计何时投产、何时财务转固？迈瑞医疗回复：您好，谢谢关注。迈瑞医疗全球制造基地——龙华科技产业园已于2022年启动建设。龙华基地用地面积约为12.8万平方米，总投资22亿元，建成后将承载公司60%以上的产能。龙华科技产业园将全面推进智能化、自动化、信息化发展，将自身打造成为医疗器械行业的制造标杆。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300760":"迈瑞医疗","LU1720050803.USD":"安联全方位中国股票基金","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","LU2153592121.USD":"Aberdeen Standard SICAV I - Emerging Markets Sustainable Development Equity A Acc USD","LU0650527681.SGD":"Fidelity China Consumer A-SGD","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU0605514214.HKD":"FIDELITY CHINA CONSUMER \"A\" (HKD) ACC","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","IE00B031HY20.USD":"FSSA CHINA GROWTH \"I\" (USD) INC","LU0594300179.USD":"FIDELITY CHINA CONSUMER \"A\" (USD) ACC","LU2153591404.USD":"Aberdeen Standard SICAV I - Asian Sustainable Development Equity A Acc USD","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","IE0005HP3H50.USD":"GUINNESS CHINA \"C\" (USD) ACC","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU1997245177.USD":"安联神洲A股基金","LU2348774022.SGD":"Aberdeen Standard SICAV I - Emerging Markets Sustainable Development Equity A Acc SGD-H","LU0084288322.USD":"Natixis Asia Equity RD USD","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","BK0251":"专用设备","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","IE0031814852.USD":"FSSA GREATER CHINA GROWTH \"I\" (USD) ACC","LU0594300419.USD":"富达中国消费基金A","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU1146622755.USD":"安本中国A股股票基金A Acc","SGXZ81163826.USD":"UNITED CHINA A-SHARES INNOVATION \"A\" (USD) ACC","LU1734074674.USD":"NINETY ONE GSF ASIA PACIFIC FRANCHISE \"A\"(USD) ACC","IE0008368742.USD":"首域中国增长基金I Acc","SGXZ49509284.SGD":"United China A Shares Innovation A Acc SGD","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","LU2348773727.SGD":"Aberdeen Standard SICAV I - Asian Sustainable Development Equity A Acc SGD-H","LU2213484517.USD":"FRANKLIN TEMPLETON CHINA A-SHARES \"A\" (USD) ACC","LU0823426480.USD":"法巴中国股票经典Dis","LU2424517915.HKD":"abrdn SICAV I -  ASIAN SDG EQUITY \"A\" (HKD) ACC","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","LU0823426308.USD":"法巴中国股票基金","IE00B29SXG58.USD":"FSSA CHINA FOCUS \"I\" (USD) ACC","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","IE00B031J352.USD":"FSSA GREATER CHINA GROWTH \"I\" (USD) INC","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","LU0359201612.USD":"贝莱德中国基金A2","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU1688375341.USD":"贝莱德中国灵活股票基金"},"translate_title":"Mindray Medical: Construction of the Longhua Science and Technology Industrial Park began in 2022.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300760":1.5},"content_text":"证券之星消息，迈瑞医疗(300760)09月01日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问深圳龙华迈瑞医疗供应链科技园一期有无完成竣工验收及竣工备案，预计何时投产、何时财务转固？迈瑞医疗回复：您好，谢谢关注。迈瑞医疗全球制造基地——龙华科技产业园已于2022年启动建设。龙华基地用地面积约为12.8万平方米，总投资22亿元，建成后将承载公司60%以上的产能。龙华科技产业园将全面推进智能化、自动化、信息化发展，将自身打造成为医疗器械行业的制造标杆。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2664310108","isCrawlerRequest":true}